Fig. 2From: Wilms’ tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5pImmune microenvironment analyses between the high and low WT1 expression groups in the TCGA cohort. (A) Comparison of the difference of immune cell fractions between high and low WT1 expression groups via CIBERSORT method. (B-D) The differences of ESTIMATE scores, IMMUNE scores and Stromal Scores between high and low WT1 expression groups. (E) The differential expression of four common immune checkpoints between high and low WT1 expression groups. Wilcox test were used for data analysisBack to article page